Recent Posts
- ELVN-001 shows cancer-killing potential in Phase 1 CML study
- Adding elraglusib seen to improve survival in pancreatic cancer trial
- New partners to help develop CAR T-cell therapy for brain cancer
- Testosterone in gender-affirming care doesn’t raise cancer risk
- IGI’s relapsed/refractory multiple myeloma drug wins fast track status